Treatment | Cases (n=20) | Controls (n=60) | OR (CI) | P value |
Steroids | 6/20 | 49/60 | 0.10 (0.03 to 0.31) | <0.001*† |
Hydroxychloroquine | 14/20 | 60/60 | Not applicable | <0.001† |
Azathioprine | 6/20 | 17/60 | 1.08 (0.36 to 3.29) | 0.89 |
Mycophenolate mofetil | 5/20 | 18/60 | 0.78 (0.25 to 2.46) | 0.67 |
Cyclophosphamide | 3/20 | 6/60 | 1.59 (0.36 to 7.04) | 0.54 |
Rituximab | 3/20 | 3/60 | 3.35 (0.62 to 18.16) | 0.14 |
Belimumab | 1/20 | 4/60 | 0.74 (0.08 to 7.01) | 0.79 |
*Remained significant in multivariate analysis.
†Bold indicates statistical significance.